视网膜器官镜像CRISPR-Cas9基因编辑效率观察到in vivo
Juliette Pulman1, Hugo Malki1, Paul Oudin1
1Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, 75012 Paris, France.
Molecular therapy. Methods & clinical development
|December 11, 2025
概括
人类视网膜器官精确地模拟了遗传性视网膜疾病的体内基因编辑结果. 这证实了它们在临床试验之前用于优化CRISPR-Cas9基因疗法.
科学领域:
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
- 再生医学是一种再生医学.
背景情况:
- 人类视网膜器官在体内模仿视网膜结构和细胞类型.
- 它们是基因疗法开发的有希望的临床前模型.
- 它们对优化基因编辑疗法的实用性仍未得到充分研究.
研究的目的:
- 评估视网膜有机体作为优化CRISPR-Cas9基因编辑的模型.
- 为了比较视网膜器官中的编辑效率与体外细胞和体外模型.
- 专注于用于自体主导视网膜炎色素性 (adRP) 基因治疗的RHO基因.
主要方法:
- 培养的人类视网膜器官和HEK293T细胞.
- 使用了两个具有RHO突变的人性化小鼠模型.
- 使用AAV和RNP系统比较了CRISPR-Cas9传递和编辑效率.
主要成果:
- 视网膜有机体的传染效率低于HEK293T细胞.
- 机器人编辑效率与实体小鼠模型结果密切相匹配.
- 在有机体和小鼠视网膜之间,CRISPR-Cas9传递模式是一致的.
结论:
- 视网膜有机体作为优化基因编辑的有价值的临床前模型.
- 它们为遗传性视网膜疾病提供了体内相关的编辑结果.
- 这有助于推进基因疗法研究,以治疗adRP等疾病.
相关概念视频
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR and crRNAs
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR/Cas9 Genome Editing
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...


